SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral

Gonzalo Ferreira1, Axel Santander1, Florencia Savio1

  • 1Laboratory of Ion Channels, Biological Membranes and Cell Signaling, Department of Biophysics, Faculty of Medicine, Universidad de la República, Montevideo, Uruguay.

Insights

Emerging infectious diseases like SARS-CoV-2, Zika virus, and Mycoplasma species pose significant risks during pregnancy and early childhood. Understanding their mechanisms and treatments is crucial for maternal and infant health.

Area of Science:

  • Microbiology
  • Virology
  • Epidemiology

Background:

  • Emerging infectious diseases are a growing threat due to environmental changes and molecular evolution.
  • Morbidity and mortality from endemic and pandemic infections impact global health.
  • Pregnancy and early childhood are critical periods for understanding infectious disease impacts.

Observation:

  • Focuses on three key pathogens: SARS-CoV-2 virus, Zika virus, and Mycoplasma species.
  • Examines structural characteristics, pathogenic mechanisms, and clinical presentations.
  • Highlights vertical transmission and neurological sequelae of Zika virus infections.

Findings:

  • SARS-CoV-2 evolved from zoonotic viruses, causing a major pandemic.
  • Zika virus poses an expanding threat linked to climate change, with significant pregnancy implications.
  • Mycoplasma species, once overlooked, are now recognized as important co-infections.

Implications:

  • Understanding these pathogens is vital for managing infections in pregnant individuals, fetuses, and neonates.
  • Research into treatments and vaccines, particularly for SARS-CoV-2, is essential.
  • This work contributes to a better appreciation of infectious disease effects on maternal and child health.

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
523
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
9.4K
Introduction to Virus01:28

Introduction to Virus

Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...
468
What are Viruses?00:50

What are Viruses?

Overview
120.8K
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.0K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
35.4K